HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hematologic profile and lymphocyte subpopulations in hemoglobin SC disease: comparison with hemoglobin SS and black controls. The Transfusion Safety Study Group.

Abstract
Compared with subjects with homozygous SS disease (Hb SS), persons with hemoglobin SC (Hb SC) are known to have a more gradual loss of splenic function, a lower incidence of bacterial infections, and fewer end-organ failures. We studied hematological indices and lymphocyte subpopulations of 27 Hb SC subjects and compared them with 173 Hb SS patients and 131 black controls. Hb SC patients had higher hemoglobin levels than Hb SS subjects, lower total leukocyte, granulocyte, monocyte, and lymphocyte counts. Platelets decreased with age but not significantly, instead of increasing as among Hb SS patients. Mononuclear cells were generally similar to controls with the exception of CD8+HLA-DR+ counts resembling Hb SS. Hematologic changes in Hb SC are limited to moderate granulocytosis in children and adults, mild monocytosis in adults, and increased activation of just one lymphocyte subset among those measured.
AuthorsW Y Wong, Y Zhou, E A Operskalski, J Hassett, D R Powars, J W Mosley
JournalAmerican journal of hematology (Am J Hematol) Vol. 52 Issue 3 Pg. 150-4 (Jul 1996) ISSN: 0361-8609 [Print] United States
PMID8756079 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • CD4 Antigens
  • CD8 Antigens
  • HLA-DR Antigens
  • Hemoglobin, Sickle
Topics
  • Adolescent
  • Black People
  • CD4 Antigens (analysis)
  • CD8 Antigens (analysis)
  • Child
  • Child, Preschool
  • HLA-DR Antigens (analysis)
  • Hemoglobin SC Disease (blood)
  • Hemoglobin, Sickle (analysis)
  • Humans
  • Infant
  • Leukocyte Count
  • Lymphocyte Subsets (immunology, pathology)
  • Reference Values

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: